FIELD: organic chemistry, biochemistry, medicine, pharmacy.
SUBSTANCE: invention relates to immunostimulating agents representing oligodeoxynucleotides of the formula (I): wherein any X represents oxygen (O) or sulfur (S) atom and wherein NMP represents deoxynucleoside monophosphate or monothiophosphate chosen from the group consisting of deoxyadenosine-, deoxyguanosine-, deoxy-inosine-, deoxycytidine-, deoxyuridine-, deoxythymidine-, 2-methyldeoxyinosine-, 5-methyldeoxycytidine-, deoxypseudouridine-, deoxyribosepurine-, 2-aminodeoxyribosepurine-, 6-S-deoxyguanosine-, 2-dimethyldeoxyguanosine- or N-isopentenyldeoxyadenosine monophosphate or monothiophosphate; NUC represents 2'-deoxynucleoside chosen from the group consisting of deoxyadenosine-, deoxyguanosine-, deoxyinosine-, deoxycytidine-, deoxyuridine-, deoxythymidine-, 2-methyldeoxyinosine-, 5-methyldeoxycytidine-, deoxypseudouridine, -deoxyribosepurine-, 2-aminodeoxyribosepurine-, 6-S-deoxyguanosine-, 2-dimethyldeoxyguanosine- or N-isopentenyldeoxyadenosine; a and b are whole numbers from 0 to 100 under condition that a + b = 4-150; B and E are groups that are usual for 5'- and 3'-end of these molecules. Also, invention relates to immunostimulating pharmaceutical compositions containing indicated an immunostimulating agent or indicated an immunostimulating agent and antigen.
EFFECT: valuable medicinal property of oligodeoxynucleotides.
15 cl, 9 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
VACCINE COMPOSITION CONTAINING IMMUNE-STIMULATING OLIGODEOXYNYCLEOTIDES | 2001 |
|
RU2413520C2 |
ALLOGENEIC ANTITUMOR THERAPEUTIC MEDICATION | 2004 |
|
RU2354694C2 |
COMPLEX CONTAINING AN OLIGONUCLEOTIDE, HAVING IMMUNOSTIMULATING ACTIVITY, AND ITS APPLICATION | 2014 |
|
RU2723943C2 |
VACCINE COMPOSITION | 2001 |
|
RU2328305C2 |
METHODS OF TREATMENT OF DISEASES ASSOCIATED WITH HPV | 2019 |
|
RU2799784C2 |
INTRACELLULAR DELIVERY OF BIOMOLECULES FOR IMMUNE RESPONSE MODULATION | 2019 |
|
RU2819143C2 |
COMPOSITION FOR TREATING PROSTATE CANCER | 2008 |
|
RU2583004C2 |
MODIFIED SUPERCOILED PROTEINS WITH IMPROVED PROPERTIES | 2013 |
|
RU2677799C2 |
VACCINE BASED ON B-CELLS, LOADED WITH LIGANDS OF T-CELLS-NATURAL KILLERS AND ANTIGEN | 2006 |
|
RU2420311C2 |
COMPOSITION FOR TREATING PROSTATE CARCINOMA (PC) | 2008 |
|
RU2508125C2 |
Authors
Dates
2007-02-20—Published
2001-06-07—Filed